Virus News and Research

Latest Virus News and Research

New fluorogenic probe could quickly detect the presence of influenza A virus

The influenza A virus, which is responsible for seasonal flu outbreaks, is also the only influenza virus that has previously caused flu pandemics.

6 Jun 2022

Autoantibody found to cause schizophrenia-like behaviors in mice

Schizophrenia is a disorder that affects how people act, think, and perceive reality. It is often very difficult to treat because it has many different causes and symptoms.

6 Jun 2022

Infants exposed to COVID-19 in the womb exhibit differences in neurodevelopmental outcomes

Babies born to mothers who suffered COVID-19 disease during pregnancy seem to exhibit differences in neurodevelopmental outcomes at 6 weeks, according to a preliminary analysis presented in the 30th European Congress of Psychiatry.

6 Jun 2022

Persistence of viral RNA following acute infection

Professor Diane Griffin from the Johns Hopkins Bloomberg School of Public Health, USA, has recently explained the persistence mechanism of viral RNA in the human body after clinical recovery from acute infection.

6 Jun 2022

Long-term exposure to air pollution associated with greater risk of severe COVID-19

Long-term exposure to air pollution is linked to a greater risk of severe COVID-19, new research being presented at Euroanaesthesia, the annual meeting of the European Society of Anaesthesiology and Intensive Care (ESAIC) in Milan, Italy (4-6 June), finds.

6 Jun 2022

Details of SARS-CoV-2 seroprevalence surveys supported by the US CDC

Researchers reviewed and analyzed data from SARS-CoV-2 serosurveys supported by the United States Centers for Disease Prevention and Control in the low- and middle-income countries.

6 Jun 2022

The impact of government-mandated proof of vaccination requirements on COVID-19 vaccine uptake

Researchers analyzed the impact of the SARS-CoV-2 vaccination mandate on vaccine uptake.

6 Jun 2022

The frequency and nature of RNA errors in both SARS-CoV-2 and its vaccine

A recent article demonstrated that SARS-CoV-2 mutants and vaccine variability stem from ribonucleic acid polymerase inaccuracy.

6 Jun 2022

Epidemiology and the public health response of monkeypox

Monkeypox is a zoonotic disease, i.e. it can be transmitted between animals and humans via direct or indirect contacts.

3 Jun 2022

Vaccine effectiveness against SARS-CoV-2 reinfection during periods with different dominant SARS-CoV-2 variants

A new study found that despite a lower COVID-19 vaccine efficacy against reinfection with the Omicron variant, these vaccines demonstrate a marked efficacy against reinfection with SARS-CoV-2 Alpha and Delta variants, as well as the Omicron variant.

3 Jun 2022

The effect of BNT162b2 mRNA COVID-19 vaccine on human semen

Scientists from Italy have recently analyzed the effect of the mRNA-based COVID-19 vaccine on the semen quality of adult men.

3 Jun 2022

A system for detecting emerging SARS-CoV-2 variants

An article published in the journal Nature Medicine examines the unpredictable evolution of the ongoing COVID-19 pandemic.

2 Jun 2022

Brain motor and fear circuits orchestrate the immune response to acute stress

A new study explores how acute stressors affected mice in terms of their immune responses in specific regions of the brain.

2 Jun 2022

Vaccine-induced immunity against severe COVID-19 remains high for about six months

Protection against symptomatic COVID-19 begins to decrease after one month from initial vaccination, while immunity against severe COVID-19 remains high for about six months, according to a recent study by Penn State College of Medicine scientists.

2 Jun 2022

COVID-19 superspreader events typically originate from few carriers

A recent research paper published in the journal Physics of Fluids analyzed the overdispersion in the coronavirus disease 2019 (COVID-19) airborne transmission.

2 Jun 2022

Immune modulator drugs improved clinical status, reduced deaths among patients hospitalized with COVID-19

A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept - drugs widely used to treat certain autoimmune diseases - did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths.

2 Jun 2022